Serum uromodulin is inversely associated with biomarkers of subclinical inflammation in the population-based KORA F4 study.
Cornelia ThenChristian HerderHolger ThenBarbara ThorandCornelia HuthMargit HeierChrista MeisingerAnnette PetersWolfgang KoenigWolfgang RathmannMichael RodenMichael StumvollHaifa MaalmiThomas MeitingerAndreas LechnerJürgen ScherberichJochen SeisslerPublished in: Clinical kidney journal (2020)
sUmod was inversely associated with biomarkers of subclinical inflammation in older participants of the KORA F4 study. The association of sUmod with IL-6 differed between women and men. Future research should focus on whether the immunomodulatory properties of sUmod are one explanation for the association of sUmod with cardiovascular outcomes and mortality.